Form 144 PROCEPT BioRobotics Corp For: 7 March
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Procept Biorobotics Corp (PRCT)
Procept Biorobotics Corp stock price live, this page displays NASDAQ PRCT stock exchange data. View the PRCT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Procept Biorobotics Corp real time stock price chart below.
What Is the Procept Biorobotics Corp Stock Price Today?
The Procept Biorobotics Corp stock price today is 24.22.
What Is the Stock Symbol for Procept Biorobotics Corp?
The stock symbol for Procept Biorobotics Corp is "PRCT."
What Stock Exchange Does Procept Biorobotics Corp Trade On?
Procept Biorobotics Corp is listed and trades on the NASDAQ stock exchange.
Is Procept Biorobotics Corp a Good Stock to Buy?
Determining whether Procept Biorobotics Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PRCT quote. (ISIN: US74276L1052)
What Is the Procept Biorobotics Corp Stock Price Today?
The Procept Biorobotics Corp stock price today is 24.22.
What Is the Stock Symbol for Procept Biorobotics Corp?
The stock symbol for Procept Biorobotics Corp is "PRCT."
What Stock Exchange Does Procept Biorobotics Corp Trade On?
Procept Biorobotics Corp is listed and trades on the NASDAQ stock exchange.
Is Procept Biorobotics Corp a Good Stock to Buy?
Determining whether Procept Biorobotics Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PRCT quote. (ISIN: US74276L1052)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
22.77
24.71
52 wk Range
19.35
66.85
PRCT is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
22.7724.71
52 wk Range
19.3566.85
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PRCT Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
32.50
Upside
+34.19%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
7 analysts have revised their earnings downwards for the upcoming period
- Form 144 PROCEPT BioRobotics Corp For: 7 March
- Investing.com
- Form 8K Procept Biorobotics Corp For: 6 March
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Procept Biorobotics Corp Company Profile
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Procept Biorobotics Corp Earnings Call Summary for Q4/2025
- Procept Biorobotics missed Q4 2025 forecasts with EPS of -$0.53 vs. expected -$0.32 and revenue of $76.1M vs. $93.77M; stock rose 2.13% after-hours.
- Gross margin declined to 60.6% from 64% year-over-year due to lower consumable revenue and voluntary field action costs; net loss widened to $29.8M.
- U.S. procedure volume surged 69% year-over-year; company implementing commercial organization restructuring to drive efficiency and growth.
- Q1 2026 guidance: EPS -$0.36 on revenue of $92.91M; Q2 forecast: EPS -$0.29 on revenue of $102.17M; plans to place ~220 new systems in 2026.
- Management confident in Aquablation technology's market potential despite margin pressures, competitive landscape, and tariff concerns affecting profitability.
Last Updated: 02/26/2026, 07:00 AM
Read Full TranscriptCompare PRCT to Peers and Sector
Metrics to compare | PRCT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPRCTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −14.3x | −1.6x | −0.5x | |
PEG Ratio | −7.58 | −0.08 | 0.00 | |
Price/Book | 3.7x | 9.4x | 2.6x | |
Price / LTM Sales | 4.4x | 4.7x | 3.2x | |
Upside (Analyst Target) | 25.9% | 41.7% | 51.4% | |
Fair Value Upside | Unlock | 17.4% | 8.5% | Unlock |
Analyst Ratings
9 Buy
3 Hold
1 Sell
Ratings:
13 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 32.50
(+34.19% Upside)
Earnings
Latest Release
Feb 25, 2026
EPS / Forecast
-0.53 / -0.32
Revenue / Forecast
76.10M / 93.77M
People Also Watch
FAQ
What Is the Procept Biorobotics (PRCT) Stock Price Today?
The Procept Biorobotics stock price today is 24.22 USD.
What Stock Exchange Does Procept Biorobotics Trade On?
Procept Biorobotics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Procept Biorobotics?
The stock symbol for Procept Biorobotics is "PRCT."
What Is the Procept Biorobotics Market Cap?
As of today, Procept Biorobotics market cap is 1.37B USD.
What Is Procept Biorobotics's Earnings Per Share (TTM)?
The Procept Biorobotics EPS (TTM) is -1.72.
When Is the Next Procept Biorobotics Earnings Date?
Procept Biorobotics will release its next earnings report on Apr 30, 2026.
From a Technical Analysis Perspective, Is PRCT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Procept Biorobotics Stock Split?
Procept Biorobotics has split 0 times.
How Many Employees Does Procept Biorobotics Have?
Procept Biorobotics has 888 employees.
What is the current trading status of Procept Biorobotics (PRCT)?
As of Mar 07, 2026, Procept Biorobotics (PRCT) is trading at a price of 24.22 USD, with a previous close of 25.35 USD. The stock has fluctuated within a day range of 22.77 USD to 24.71 USD, while its 52-week range spans from 19.35 USD to 66.85 USD.
What Is Procept Biorobotics (PRCT) Price Target According to Analysts?
The average 12-month price target for Procept Biorobotics is 32.50 USD, with a high estimate of 51 USD and a low estimate of 20 USD. 9 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +34.19% Upside potential.
What Is the PRCT Premarket Price?
PRCT's last pre-market stock price is 24.02 USD. The pre-market share volume is 31,360.00, and the stock has decreased by -1.33, or -5.25%.
What Is the PRCT After Hours Price?
PRCT's last after hours stock price is 24.19 USD, the stock has decreased by -0.03, or -0.12%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.